252 related articles for article (PubMed ID: 11714889)
1. Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-à-gogo K(+) channel.
Potet F; Bouyssou T; Escande D; Baró I
J Pharmacol Exp Ther; 2001 Dec; 299(3):1007-12. PubMed ID: 11714889
[TBL] [Abstract][Full Text] [Related]
2. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
Rampe D; Roy ML; Dennis A; Brown AM
FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
[TBL] [Abstract][Full Text] [Related]
3. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.
Mohammad S; Zhou Z; Gong Q; January CT
Am J Physiol; 1997 Nov; 273(5):H2534-8. PubMed ID: 9374794
[TBL] [Abstract][Full Text] [Related]
4. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states.
Walker BD; Singleton CB; Bursill JA; Wyse KR; Valenzuela SM; Qiu MR; Breit SN; Campbell TJ
Br J Pharmacol; 1999 Sep; 128(2):444-50. PubMed ID: 10510456
[TBL] [Abstract][Full Text] [Related]
6. Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels.
Kuryshev YA; Brown AM; Wang L; Benedict CR; Rampe D
J Pharmacol Exp Ther; 2000 Nov; 295(2):614-20. PubMed ID: 11046096
[TBL] [Abstract][Full Text] [Related]
7. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations.
Ficker E; Obejero-Paz CA; Zhao S; Brown AM
J Biol Chem; 2002 Feb; 277(7):4989-98. PubMed ID: 11741928
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel.
Walker BD; Singleton CB; Tie H; Bursill JA; Wyse KR; Valenzuela SM; Breit SN; Campbell TJ
Cardiovasc Res; 2000 Oct; 48(1):44-58. PubMed ID: 11033107
[TBL] [Abstract][Full Text] [Related]
9. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG.
Rampe D; Murawsky MK; Grau J; Lewis EW
J Pharmacol Exp Ther; 1998 Aug; 286(2):788-93. PubMed ID: 9694935
[TBL] [Abstract][Full Text] [Related]
10. Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.
Kang J; Chen XL; Wang L; Rampe D
J Pharmacol Exp Ther; 2001 Oct; 299(1):290-6. PubMed ID: 11561091
[TBL] [Abstract][Full Text] [Related]
11. Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels.
Chen J; Seebohm G; Sanguinetti MC
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12461-6. PubMed ID: 12209010
[TBL] [Abstract][Full Text] [Related]
12. Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders.
Drolet B; Rousseau G; Daleau P; Cardinal R; Turgeon J
Circulation; 2000 Oct; 102(16):1883-5. PubMed ID: 11034933
[TBL] [Abstract][Full Text] [Related]
13. The 5-HT(4) agonists cisapride, mosapride, and CJ-033466, a Novel potent compound, exhibit different human ether-a-go-go-related gene (hERG)-blocking activities.
Toga T; Kohmura Y; Kawatsu R
J Pharmacol Sci; 2007 Oct; 105(2):207-10. PubMed ID: 17928736
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.
Paul AA; Witchel HJ; Hancox JC
Br J Pharmacol; 2002 Jul; 136(5):717-29. PubMed ID: 12086981
[TBL] [Abstract][Full Text] [Related]
15. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents.
Katchman AN; McGroary KA; Kilborn MJ; Kornick CA; Manfredi PL; Woosley RL; Ebert SN
J Pharmacol Exp Ther; 2002 Nov; 303(2):688-94. PubMed ID: 12388652
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the human ether-a-gogo related gene (HERG) K+ channels by reactive oxygen species.
Taglialatela M; Castaldo P; Iossa S; Pannaccione A; Fresi A; Ficker E; Annunziato L
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11698-703. PubMed ID: 9326673
[TBL] [Abstract][Full Text] [Related]
17. Kinetic modulation of HERG potassium channels by the volatile anesthetic halothane.
Li J; Correa AM
Anesthesiology; 2002 Oct; 97(4):921-30. PubMed ID: 12357160
[TBL] [Abstract][Full Text] [Related]
18. Blockade of HERG and Kv1.5 by ketoconazole.
Dumaine R; Roy ML; Brown AM
J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
[TBL] [Abstract][Full Text] [Related]
19. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.
Paul AA; Witchel HJ; Hancox JC
Biochem Biophys Res Commun; 2001 Feb; 280(5):1243-50. PubMed ID: 11162661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]